192 related articles for article (PubMed ID: 26540629)
1. Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway.
Qin G; Xu F; Qin T; Zheng Q; Shi D; Xia W; Tian Y; Tang Y; Wang J; Xiao X; Deng W; Wang S
Oncotarget; 2015 Dec; 6(39):41794-808. PubMed ID: 26540629
[TBL] [Abstract][Full Text] [Related]
2. COX-2 induces oncogenic micro RNA miR655 in human breast cancer.
Majumder M; Dunn L; Liu L; Hasan A; Vincent K; Brackstone M; Hess D; Lala PK
Sci Rep; 2018 Jan; 8(1):327. PubMed ID: 29321644
[TBL] [Abstract][Full Text] [Related]
3. Manganese-12 acetate suppresses the migration, invasion, and epithelial-mesenchymal transition by inhibiting Wnt/β-catenin and PI3K/AKT signaling pathways in breast cancer cells.
Ju H; Li Y; Xing X; Miao X; Feng Y; Ren Y; Qin J; Liu D; Chen Z; Yang Z
Thorac Cancer; 2018 Mar; 9(3):353-359. PubMed ID: 29316252
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression.
Larkins TL; Nowell M; Singh S; Sanford GL
BMC Cancer; 2006 Jul; 6():181. PubMed ID: 16831226
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological inhibition of platelet-tumor cell cross-talk prevents platelet-induced overexpression of cyclooxygenase-2 in HT29 human colon carcinoma cells.
Dovizio M; Maier TJ; Alberti S; Di Francesco L; Marcantoni E; Münch G; John CM; Suess B; Sgambato A; Steinhilber D; Patrignani P
Mol Pharmacol; 2013 Jul; 84(1):25-40. PubMed ID: 23580446
[TBL] [Abstract][Full Text] [Related]
6. Combining lapatinib and palbociclib inhibits cell proliferation and invasion via AKT signaling pathway in endocrine-resistant breast cancer cells.
Horpratraporn K; Adchariyasakulchai P; Sainamthip P; Ketchart W
Med Oncol; 2024 Jan; 41(2):58. PubMed ID: 38231469
[TBL] [Abstract][Full Text] [Related]
7. Induction of DNMT3B by PGE2 and IL6 at Distant Metastatic Sites Promotes Epigenetic Modification and Breast Cancer Colonization.
So JY; Skrypek N; Yang HH; Merchant AS; Nelson GW; Chen WD; Ishii H; Chen JM; Hu G; Achyut BR; Yoon EC; Han L; Huang C; Cam MC; Zhao K; Lee MP; Yang L
Cancer Res; 2020 Jun; 80(12):2612-2627. PubMed ID: 32265226
[TBL] [Abstract][Full Text] [Related]
8. Melatonin Represses Metastasis in Her2-Postive Human Breast Cancer Cells by Suppressing RSK2 Expression.
Mao L; Summers W; Xiang S; Yuan L; Dauchy RT; Reynolds A; Wren-Dail MA; Pointer D; Frasch T; Blask DE; Hill SM
Mol Cancer Res; 2016 Nov; 14(11):1159-1169. PubMed ID: 27535706
[TBL] [Abstract][Full Text] [Related]
9. Epithelial-mesenchymal transition increases tumor sensitivity to COX-2 inhibition by apricoxib.
Kirane A; Toombs JE; Larsen JE; Ostapoff KT; Meshaw KR; Zaknoen S; Brekken RA; Burrows FJ
Carcinogenesis; 2012 Sep; 33(9):1639-46. PubMed ID: 22678114
[TBL] [Abstract][Full Text] [Related]
10. Small size fullerenol nanoparticles suppress lung metastasis of breast cancer cell by disrupting actin dynamics.
Qin Y; Chen K; Gu W; Dong X; Lei R; Chang Y; Bai X; Xia S; Zeng L; Zhang J; Ma S; Li J; Li S; Xing G
J Nanobiotechnology; 2018 Jun; 16(1):54. PubMed ID: 29935539
[TBL] [Abstract][Full Text] [Related]
11. Cancer cells display increased migration and deformability in pace with metastatic progression.
Liu Z; Lee SJ; Park S; Konstantopoulos K; Glunde K; Chen Y; Barman I
FASEB J; 2020 Jul; 34(7):9307-9315. PubMed ID: 32463148
[TBL] [Abstract][Full Text] [Related]
12. Stromal Senescence following Treatment with the CDK4/6 Inhibitor Palbociclib Alters the Lung Metastatic Niche and Increases Metastasis of Drug-Resistant Mammary Cancer Cells.
Gallanis GT; Sharif GM; Schmidt MO; Friedland BN; Battina R; Rahhal R; Davis JE; Khan IS; Wellstein A; Riegel AT
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980794
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil-activating secretome characterizes palbociclib-induced senescence of breast cancer cells.
Favaretto G; Rossi MN; Cuollo L; Laffranchi M; Cervelli M; Soriani A; Sozzani S; Santoni A; Antonangeli F
Cancer Immunol Immunother; 2024 May; 73(6):113. PubMed ID: 38693312
[TBL] [Abstract][Full Text] [Related]
14. Palbociclib releases the latent differentiation capacity of neuroblastoma cells.
Ferguson KM; Gillen SL; Chaytor L; Poon E; Marcos D; Gomez RL; Woods LM; Mykhaylechko L; Elfari L; Martins da Costa B; Jamin Y; Carroll JS; Chesler L; Ali FR; Philpott A
Dev Cell; 2023 Oct; 58(19):1967-1982.e8. PubMed ID: 37734383
[TBL] [Abstract][Full Text] [Related]
15. Sarcophine-diol inhibits expression of COX-2, inhibits activity of cPLA2, enhances degradation of PLA2 and PLC(γ)1 and inhibits cell membrane permeability in mouse melanoma B16F10 cells.
Szymanski PT; Muley P; Ahmed SA; Khalifa S; Fahmy H
Mar Drugs; 2012 Oct; 10(10):2166-2180. PubMed ID: 23170076
[TBL] [Abstract][Full Text] [Related]
16. Breathless on the journey: Unmasking palbociclib-induced pneumonitis in a geriatric breast cancer warrior.
Arshad AM; Babiker M; Sulaiman T; Al Adab A
Qatar Med J; 2024; 2024(2):19. PubMed ID: 38686371
[No Abstract] [Full Text] [Related]
17. Efficacy of the combination of MEK and CDK4/6 inhibitors in vitro and in vivo in KRAS mutant colorectal cancer models.
Lee MS; Helms TL; Feng N; Gay J; Chang QE; Tian F; Wu JY; Toniatti C; Heffernan TP; Powis G; Kwong LN; Kopetz S
Oncotarget; 2016 Jun; 7(26):39595-39608. PubMed ID: 27167191
[TBL] [Abstract][Full Text] [Related]
18. Palbociclib (PD0332991)-a Selective and Potent Cyclin-Dependent Kinase Inhibitor: A Review of Pharmacodynamics and Clinical Development.
Clark AS; Karasic TB; DeMichele A; Vaughn DJ; O'Hara M; Perini R; Zhang P; Lal P; Feldman M; Gallagher M; O'Dwyer PJ
JAMA Oncol; 2016 Feb; 2(2):253-60. PubMed ID: 26633733
[TBL] [Abstract][Full Text] [Related]
19. Coadministration of Trametinib and Palbociclib Radiosensitizes KRAS-Mutant Non-Small Cell Lung Cancers In Vitro and In Vivo.
Tao Z; Le Blanc JM; Wang C; Zhan T; Zhuang H; Wang P; Yuan Z; Lu B
Clin Cancer Res; 2016 Jan; 22(1):122-33. PubMed ID: 26728409
[TBL] [Abstract][Full Text] [Related]
20. Targeted Therapies Overcoming Endocrine Resistance in Hormone Receptor-Positive Breast Cancer.
Almstedt K; Schmidt M
Breast Care (Basel); 2015 Jul; 10(3):168-72. PubMed ID: 26557821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
